Articles Tagged With: FDA
-
Medication Abortion Through Telehealth Is Safe, Effective, and Convenient
Researchers began studying the safety and effectiveness of telehealth medication abortions in 2021 and concluded in 2022 before the U.S. Supreme Court decision to overturn Roe v. Wade. The recently published results showed that telehealth medication abortions are safe, with outcomes of 99.8% without serious adverse events.
-
Telehealth Medication Abortion Remains Under Threat Even as Access Expands
In June, the U.S. Supreme Court is expected to decide the fate of the abortion medication mifepristone — a decision that could undermine access to the medication at a time when major pharmacies and retailers have begun to offer the pill. Abortion rights advocates, reproductive health clinicians, and others are bracing for a decision that could upend access to safe, legal self-managed abortions for most or all women in the nation.
-
AI Creates Liability Risks for Healthcare Organizations
Artificial intelligence is entering a variety of industries including healthcare, where it offers the opportunity to improve diagnoses and patient care in many ways. The potential benefits come with significant risks that must be anticipated and mitigated.
-
Improve Screening and Retesting for Trichomoniasis
Infection by the protozoan Trichomonas vaginalis is the most common nonviral sexually transmitted infection, with an estimated 6.8 million cases in the United States annually. It can go undiagnosed because most infected people (up to three out of four) do not experience symptoms. Left undiagnosed and untreated, trichomoniasis can increase the risk of pelvic inflammatory disease, infertility, and acquiring HIV and other STIs.
-
Society of Family Planning Issues Clinical Recommendation for Medication Abortion
As maternity and OB/GYN deserts spread across the United States, medication abortion to expel the fetus and placenta from the uterus without a surgical procedure is possible and can work safely and well between 14 weeks and nearly 28 weeks of gestation. There are few absolute contraindications to medication abortion from 14 to 27 weeks of gestation, according to the Society of Family Planning and Society of Maternal-Fetal Medicine’s new clinical recommendation.
-
Telemedicine Abortion Services Not as Accessible to Many in Need
Medication abortion through telehealth services has grown dramatically in the past couple of years, but it is not accessible to everyone who may need the service. For example, younger people, those with health conditions, and those with limited English proficiency are less likely to use telemedicine abortion services.
-
Forensic Nurses Need Facts on Emergency Contraception
Forensic nurses, who work with victims of violence, hold a fair amount of misinformation about how emergency contraception works, according to new research.
-
3D Contraceptive Ring Technology Holds Promise for HIV Prevention
The results of recent research suggest it is possible that women could have access to an intravaginal ring that can serve both as a contraceptive and as HIV prevention. The ring would be created through 3D printing technology. So far, it has been tested for safety in sheep, and it could be several years before clinical trials are underway.
-
Patients Desire Telemedicine for Abortion Care
New research confirms previous studies in demonstrating the safety and efficacy of medication abortion pills. Studies also show there is strong desire for this option among people seeking an end to their pregnancy.
-
What Is Next for the First OTC Birth Control Pill Approved by the FDA?
It took contraceptive care advocates more than two decades, but they achieved success on July 13, when the U.S. Food and Drug Administration approved Opill, the first over-the-counter hormonal birth control pill, for use in the United States.